Thromb Haemost 1978; 39(02): 524-525
DOI: 10.1055/s-0038-1646714
Original Article
Schattauer GmbH Stuttgart

Report on the Joint Meeting of the Task Forces on Nomenclature and Standards of Inhibitors of Coagulation and Fibrinolysis

Ulla Hedner
The Coagulation Laboratory, Malmö General Hospital, Malmö, Sweden and the Aker Hospital, Oslo, Norway
,
Ulrich Abildgaard
The Coagulation Laboratory, Malmö General Hospital, Malmö, Sweden and the Aker Hospital, Oslo, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

 
  • References

  • 1 Collen D, De Cock F, Verstraete M. 1975; Immunochemical distinction between antiplasmin and α1-antitrypsin. Thrombosis Research 7: 245
  • 2 Hedner U. 1973; Studies on an inhibitor of plasminogen activation in human serum. Thrombosis et Diathesis Haemorrhagica 30: 414
  • 3 Hedner U, Nilsson IM, Jacobsen CD. 1970; Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Scandinavian Journal of Clinical and Laboratory Investigation 25: 329
  • 4 Miller-Andersson M, Borg H, Andersson LO. 1974; Purification of antithrombin III by affinity chromatography. Thrombosis Research 5: 439
  • 5 Moroi M, Aoki N. 1976; Isolation and characterization of α2-plasmin and inhibitor from human plasma. Journal of Biological Chemistry 251: 5956
  • 6 Müllertz S. 1972; Molecular forms of plasmin and protease inhibitors in human fibrinolytic post-mortem plasma. Scandinavian Journal of Clinical and Laboratory Investigation 30: 369